DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 02 · Volume 57 · 1987 DOI: 10.1055/s-008-39933

Original Article

131
Bröcker-Vriends, A H J T; Briët, E; Quadt, R; Dreesen, J C F M; Bakker, E; Claassen-Tegelaar, R; Kanhai, H H H; van de Kamp, J J P; Pearson, P L: Genotype Assignment of Haemophilia A by Use of Intragenic and Extragenic Restriction Fragment Length Polymorphisms
137
Gram, Jørgen; Jespersen, Jørgen: A Selective Depression of Tissue Plasminogen Activator (t-PA) Activity in Euglobulins Characterises a Risk Group Among Survivors of Acute Myocardial Infarction
140
de Jong, Egbert; Knot, Eduard A R; Piket, Dick; Iburg, Alfred H C; Rijken, Dick C; Veenhof, Kees H N; Dooijewaard, Gerard; ten Cate, Jan W: Increased Plasminogen Activator Inhibition Levels in Malignancy
144
Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira: Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity
148
Van Hinsbergh, Victor W M; Sprengers, Erik D; Kooistra, Teake: Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells
154
de Moerloose, P A; Reber, G; Vernet, Ph; Minazio, Ph; Bouvier, C A: Antithrombin III Geneva: A Hereditary Abnormal AT III with Defective Heparin Cofactor Activity
158
Ushikubi, Fumitaka; Okuma, Minoru; Kanaji, Kenji; Sugiyama, Tateo; Ogorochi, Toshiya; Narumiya, Shuh; Uchino, Haruto: Hemorrhagic Thrombocytopathy with Platelet Thromboxane A2 Receptor Abnormality: Defective Signal Transduction with Normal Binding Activity
165
Hara, H; Tamao, Y; Kikumoto, R; Okamoto, S: Effect of a Synthetic Thrombin Inhibitor MCI-9038 on Experimental Models of Disseminated Intravascular Coagulation in Rabbits
171
Jansen, J W C M; Haverkate, F; Koopman, J; Nieuwenhuis, H K; Kluft, C; Boschman, Th A C: Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro
176
de Fouw, N J; van Hinsbergh, V W M; de Jong, Y F; Haverkate, F; Bertina, R M: The Interaction of Activated Protein C and Thrombin with the Plasminogen Activator Inhibitor Released from Human Endothelial Cells
183
Sala, N; Borrell, M; Bauer, K A; Viganò-D’Angelo, S; Fontcuberta, J; Félez, J; Rutllant, M L: Dysfunctional Activated Protein C (PC Cádiz) in a Patient with Thrombotic Disease
187
Handley, Dean A; Van Valen, Ronald G; Winslow, Christine M; Tomesch, John C; Saunders, Robert N: In Vitro and In Vivo Pharmacological Profiles of the PAF Receptor Antagonist SRI 63-675
191
Joseph, Sunil; Krishnamurthi, Sushila; Kakkar, Vijay V: Effect of the Polyamine-Spermine on Agonist-Induced Human Platelet Activation - Specific Inhibition of "Aggregation-Independent" Events Induced by Thrombin, but not by Collagen, Thromboxane Mimetic, Phorbol Ester or Calcium lonophore
196
Bertina, R M; van der Linden, I K; Engesser, L; Muller, H P; Brommer, E J P: Hereditary Heparin Cofactor II Deficiency and the Risk of Development of Thrombosis
201
Scarabin, P Y; Strain, L; Ludlam, C A; Jones, J; Kohner, E M: Reliability of a Single β-Thromboglobulin Measurement in a Diabetic Population : Importance of PGE1 in Anticoagulant Mixture
205
Petersen, Lars Christian; Handest, Peter; Brender, Jytte; Selmer, Johan; Jørgensen, Maja; Thorsen, Sixtus: A Sensitive Solid-Phase Immunosorbent Assay for Tissue-Type Plasminogen Activator Activity in Plasma Using Trinitrobenzoylated Poly-D-Lysine as a Stimulator for Plasminogen Activation
212
Thorsen, L I; Gaudernack, G; Brosstad, F; Pedersen, T M; Solum, N O: Identification of Platelet Antigens by Monoclonal Antibodies Using Crossed Immunoelectrophoresis with Immunoblotting of the Monoclonal Antibody
217
Enayat, M S; Hill, F G H; Robinson, W; Prowse, C V; Hornsey, V S: Evaluation of Monoclonal Antibodies to vWf Antigen for Use in Autoradiographing vWf Multimer Analysis
222
Soberay, A H; Herzberg, M C; Rudney, J D; Nieuwenhuis, H K; Sixma, J J; Seligsohn, U: Responses of Platelets to Strains of Streptococcus sanguis: Findings in Healthy Subjects, Bernard-Soulier, Glanzmann’s, and Collagen-Unresponsive Patients
226
van den Besselaar, A M H P; Meeuwisse-Braun, J; Jansen-Grüter, R; Bertina, R M: Monitoring Heparin Therapy by the Activated Partial Thromboplastin Time - The Effect of Pre-Analytical Conditions

Letters to the Editor

232
O’Brien, J R: Multiple Therapy for Multifactorial Thrombosis
233
Hoyle, Christine; Ludlam, C A: Acquired Factor VIII Inhibitor Associated with Multiple Sclerosis, Successfully Treated with Porcine Factor VIII
234
Forestier, François; Daffos, Fernand; Rainaut, Martine; Toulemonde, Francis: Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy
235
Gresele, Paolo; Amout, Jef; Vermylen, Jos: Dipyridamole Inhibits Leukotriene B4 Synthesis
236
Williams, Eliot C: Cold-Induced In Vitro Precipitation of Factor V in a Patient with Monoclonal IgM Cryoglobulinemia
238
Finazzi, Guido; Cortelazzo, Sergio; Viero, Piera; Galli, Monica; Barbui, Tiziano: Maternal Lupus Anticoagulant and Fatal Neonatal Thrombosis
239
de Prost, D; Katlama, C; Pialoux, G; Karsenty-Mathonnet, F; Wolff, M: Heparin-Like Anticoagulant Associated with AIDS
240
Schwarz, H P; Schernthaner, G; Griffin, J H: Decreased Plasma Levels of Protein S in Well-Controlled Type I Diabetes Mellitus
241
Harenberg, J; Augustin, J: Antithrombotic Action of Hepatic Triglyceride Lipase - Fact or Fictaon
242
Barrowcliffe, Trevor W: Antithrombotic Action of Hepatic Triglyceride Lipase - Fact or Fiction -Rejoinder